4.8 Article

Prevalence and risk factors of non-alcoholic fatty liver disease in the elderly: Results from the Rotterdam study

期刊

JOURNAL OF HEPATOLOGY
卷 57, 期 6, 页码 1305-1311

出版社

ELSEVIER SCIENCE BV
DOI: 10.1016/j.jhep.2012.07.028

关键词

Non-alcoholic fatty liver disease; Elderly; Epidemiology; Metabolic syndrome; Physical activity; Smoking

资金

  1. Erasmus MC University Medical Center and Erasmus University Rotterdam
  2. Netherlands Organization for Scientific Research (NWO)
  3. Netherlands Organization for Health Research and Development (ZonMw)
  4. Research Institute for Diseases in the Elderly (RIDE)
  5. Ministry of Education, Culture and Science
  6. Ministry of Health. Welfare and Sports
  7. European Commission (DG XII)
  8. Municipality of Rotterdam
  9. Foundation for Liver Research (SLO), Rotterdam, The Netherlands

向作者/读者索取更多资源

Background & Aims: The prevalence of non-alcoholic fatty liver disease (NAFLD) appears to increase with age. However, limited data are available concerning the prevalence of NAFLD in the elderly. Our aim was to determine the prevalence and risk factors of NAFLD in an elderly population. Methods: This study was based on participants in the population-based Rotterdam Study. Each participant was interviewed and had a clinical examination at the research center, including a fasting blood collection, liver ultrasonography, and anthropometric assessment. Ordinal and logistic regression analysis was used to assess associations between covariables and (severity of) NAFLD. Results: Data from 2811 participants (mean age 76.4 +/- 6.0 years) were analyzed. The prevalence of NAFLD was 35.1%. The prevalence of NAFLD decreased with advancing age (p <0.001). In logistic regression analysis, age (OR 0.97; 95% CI 0.95-0.99; p <0.001), total physical activity level (OR 0.98, 95% CI 0.96-0.99; p = 0.005), pack years of smoking (OR 1.01,95% CI 1.00-1.01; p = 0.02), waist circumference >88 cm for women and >102 cm for men (OR 4.89; CI 4.00-5.96; p <0.001), fasting glucose >= 100 mg/dl or drug treatment for elevated blood glucose (OR 2.11, 95% CI 1.72-2.59; p <0.001), blood pressure >= 130/85 mmHg or drug treatment for elevated blood pressure (OR 1.80, 95% for elevated blood pressure (OR 1.80, 95% CI 1.08-3.01; 1.08-3.01; p = 0.03), and triglycerides >= 150 mg/di or treatment with serum lipid reducing agents (OR 1.56, 95% Cl 1.28-1.91; p <0.001) were associated with NAFLD. Conclusions: NAFLD is common in the elderly, although the prevalence decreases with advancing age. Further studies are warranted exploring potential factors contributing to this apparent positive selection effect in the elderly. (C) 2012 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据